Obocon Inc. (OBCN): This is how bad this “outfit” is. My pre...

scott135 · 2021-07-22T23:31:21.1600000Z

This is how bad this “outfit” is. My previous post has not been taken down

Play Episode

10min

Proactive - Interviews for investors

GTI Energy’s Uranium Study Yields Key Results

GTI Energy Ltd CEO Bruce Lane talked with Proactive about the latest developments at the Lo Herma in-situ recovery (ISR) Uranium Project in Wyoming. Lane highlighted key findings from recent scoping study fieldwork, including updated resource estimates of 8.57 million pounds, with 30% in the indicated category. He noted that metallurgical testing produced positive leach test results, aligning with nearby uranium projects. GTI Energy also completed permeability testing and water monitoring wells, confirming sufficient water levels and favourable mineralization conditions for ISR mining. Lane emphasized that these results reinforce the feasibility of uranium extraction at Lo Herma, placing it in line with existing ISR operations in Wyoming. He outlined the company’s next steps, including finalizing the scoping study and preparing for further permitting and potential project expansion. Lane also discussed the strong uranium market fundamentals, citing U.S. utilities' annual demand of 50 million pounds versus current domestic production of only 1–2 million pounds. With growing interest in US-based uranium supply and favourable regulatory conditions, GTI Energy continues to advance its Wyoming uranium assets. For more exclusive interviews and updates, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and turn on notifications for the latest insights. #GTIEnergy #UraniumMining #LoHermaProject #ISRMining #WyomingUranium #UraniumStocks #EnergySector #MiningNews #BruceLane #NuclearEnergy

Proactive - Interviews for investors

Blockmate Ventures: Hivello’s AI expansion with Nosana

Blockmate Ventures Inc (TSX-V:MATE, OTCQB:MATEF) chairman Domenic Carosa talked with Proactive's Stephen Gunnion about Hivello’s latest integration with the Nosana network. Carosa explained that Hivello allows users to rent out their computer resources, similar to how AirBnB operates for homes. This model enables users to generate passive income while contributing to a decentralized blockchain network. The integration with Nosana enhances this model by tapping into AI demand. “Nosana is one of the leading GPU DePINs… they basically power AI,” Carosa said. He highlighted that Hivello’s users are now actively contributing to training AI models and earning from it. Carosa also discussed the recent token generation event (TGE), comparing it to an IPO in the crypto space. As of the interview, Hivello’s token had a fully diluted value of over $20 million, providing significant value to Blockmate Ventures, which owns approximately 50% of Hivello. Looking ahead, Blockmate Ventures is focused on expanding its DePIN integrations and increasing customer adoption. Carosa emphasized that the company is doubling down on AI and blockchain opportunities in 2025. For more exclusive interviews and updates, visit Proactive’s YouTube channel. Don’t forget to like, subscribe, and turn on notifications for the latest insights! #BlockmateVentures #Hivello #Nosana #AI #DePIN #Crypto #Blockchain #TokenGeneration #Web3 #PassiveIncome #TechInvesting

Proactive - Interviews for investors

Lisata Therapeutics expands drug discovery with GATC AI collaboration

Lisata Therapeutics Inc (NASDAQ:LSTA) CEO David Mazzo talked with Proactive about the company’s strategic collaboration with GATC Health, a leader in artificial intelligence-driven drug discovery. Mazzo explained that GATC’s technology, which is recognized by Lloyd’s of London for clinical trial risk assessment, will be used to analyze Lisata’s lead candidate, certepetide, and identify potential new drug combinations. Mazzo highlighted that this collaboration will optimize Lisata’s ongoing cancer research, including trials in pancreatic ductal adenocarcinoma, cholangiocarcinoma, and other cancers. He noted that GATC’s AI technology can perform billions of simulations rapidly, potentially reducing the cost and risk of drug development. Discussing Lisata’s 2025 outlook, Mazzo described it as a "data-rich year," with upcoming results from the ASCEND trial and other studies. He emphasized the potential for certepetide in combination with immunotherapy and the company’s ongoing discussions with regulatory agencies and potential partners. To watch more interviews like this, visit Proactive’s YouTube channel. Don't forget to like this video, subscribe, and enable notifications for future updates. #LisataTherapeutics #Biotech #CancerResearch #AIinHealthcare #DrugDevelopment #ClinicalTrials #GATCHealth #Pharma #Oncology #Investing

Proactive - Interviews for investors

NSX CEO highlights mining focus & direct listings as key growth drivers for 2025

National Stock Exchange of Australia CEO Max Cunningham talked with Proactive's Angela Harmantas from the PDAC conference in Toronto about the exchange’s role in the Australian market, its focus on mining companies, and its expansion plans. Cunningham explained that the NSX is one of two active stock exchanges in Australia with a tier-one license, allowing it to serve all investors, including retail. He highlighted that around one-third of the exchange’s listings are mining-related, with strong growth potential in the sector. Cunningham noted that NSX is working to fill a gap in the Australian venture market and is focusing on attracting mining companies, especially from regions like Perth. He also emphasized the importance of international relationships, mentioning cross-listing agreements with Canadian exchanges such as the CSE and TSX, as well as OTC Markets. Looking ahead to 2025, Cunningham discussed the challenges of IPOs due to regulatory hurdles and capital-raising difficulties. Instead, the NSX is prioritizing direct listings, which allow companies to go public without raising capital upfront. He stated that NSX is seeing increased interest from firms moving from the incumbent Australian exchange, as well as from Canadian companies seeking dual listings. #NSX #StockMarket #MiningStocks #IPOs #DirectListings #PDAC2025 #Investing #AustralianMarkets #DualListings #CapitalMarkets

Followers	1
Posts	104
Boards Moderated	0
Alias Born	05/07/2008

Volume:	-
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

OBCN Detailed Quote

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Go Ad-Free